On orphan drug exclusivity, FDA decides to go its own way after court loss

The FDA on Monday offered its latest perspective on how it will interpret the laws governing the seven years of orphan drug exclusivity granted to new rare disease drugs, following a controversial court loss that left many rare disease drugmakers in limbo. The agency effectively decided to return…#fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news